COMMUNIQUÉ DE PRESSE publié le 13/09/2025 à 00:00, il y a 9 mois 11 jours Onco-Innovations to Chair Colorectal Cancer Canada Precision Oncology Forum Driving the Future of Cancer Care Onco-Innovations to lead CRC Catalysts roundtable on data innovation and digital trust in oncology, advancing precision medicine. Enhanced by expert speakers, including Dr. Paul Arora Precision Medicine Digital Trust Onco-Innovations Data Innovation CRC Catalysts
BRÈVE publiée le 05/09/2025 à 15:05, il y a 9 mois 18 jours Onco-Innovations Appoints Dr. John Mackey to Advisory Board Clinical Trials Oncology John Mackey Onco-Innovations PNKP Inhibitor
BRÈVE publiée le 05/09/2025 à 15:05, il y a 9 mois 18 jours Onco-Innovations nomme le Dr John Mackey au conseil consultatif Essais Cliniques John Mackey Oncologie Onco-Innovations Inhibiteur De PNKP
COMMUNIQUÉ DE PRESSE publié le 05/09/2025 à 15:00, il y a 9 mois 18 jours Onco-Innovations Appoints Dr. John Mackey to Scientific & Clinical Advisory Board Onco-Innovations appoints Dr. John Mackey, expert in oncology and clinical trials, to Scientific & Clinical Advisory Board, enhancing translational research capabilities for PNKP inhibitor program Clinical Trials Oncology Onco-Innovations PNKP Inhibitor Dr. John Mackey
BRÈVE publiée le 15/08/2025 à 15:20, il y a 10 mois 8 jours Onco-Innovations Achieves High Warrant Exercise Rate Warrants Non-dilutive Financing Cancer Research Shareholder Confidence Capital Strategy
BRÈVE publiée le 15/08/2025 à 15:20, il y a 10 mois 8 jours Onco-Innovations atteint un taux d'exercice de mandat élevé Financement Non Dilutif Confiance Des Actionnaires Mandats Stratégie De Capital Recherche Sur Le Cancer
COMMUNIQUÉ DE PRESSE publié le 15/08/2025 à 15:15, il y a 10 mois 8 jours Onco-Innovations Announces 90% of $0.60 Warrants Have Been Exercised Onco-Innovations announces successful execution of key capital strategy with over 90% of outstanding warrants exercised at $0.60, reinforcing investor confidence and internal financing effectiveness Warrants Investor Confidence Capital Strategy Onco-Innovations Internal Financing
BRÈVE publiée le 13/08/2025 à 23:05, il y a 10 mois 10 jours Onco-Innovations clôture un placement privé de 400 000 $ Placement Privé Réglementation Des Valeurs Mobilières Actions Et Bons De Souscription Onco-Innovations Financement Et Développement
BRÈVE publiée le 13/08/2025 à 23:05, il y a 10 mois 10 jours Onco-Innovations Closes $400,000 Private Placement Private Placement Securities Regulation Shares And Warrants Onco-Innovations Funding And Development
COMMUNIQUÉ DE PRESSE publié le 13/08/2025 à 23:00, il y a 10 mois 10 jours Onco-Innovations Announces Closing of Private Placement Onco-Innovations Limited announces the closing of a non-brokered private placement, raising $400,000 for general corporate purposes and cancer research. Statutory hold period applies. Not for distribution in the US Non-brokered Private Placement Cancer Research Statutory Hold Period Onco-Innovations Limited Not For Distribution
Publié le 23/06/2026 à 19:47, il y a 9 heures 10 minutes GROUPE SFPI: reorganisation de la Direction Générale
Publié le 23/06/2026 à 19:47, il y a 9 heures 10 minutes GROUPE SFPI: General management reorganisation
Publié le 23/06/2026 à 19:10, il y a 9 heures 47 minutes GUILLEMOT CORPORATION > EVOLUTION DE LA GOUVERNANCE A COMPTER DU 23 JUIN 2026
Publié le 23/06/2026 à 19:10, il y a 9 heures 47 minutes GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026
Publié le 23/06/2026 à 18:32, il y a 10 heures 25 minutes Communiqué sur la demande de radiation auprès d'Euroclear des Droits à Complément de Prix
Publié le 24/06/2026 à 03:15, il y a 1 heure 43 minutes Noram Lithium Adopts Semi-Annual Financial Reporting
Publié le 24/06/2026 à 00:00, il y a 4 heures 58 minutes Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
Publié le 23/06/2026 à 23:45, il y a 5 heures 13 minutes Prospect Ridge Aligns with the Market Mindset for Exclusive Live Investor Interview Discussing Game-changing 2026 Drill Programs
Publié le 23/06/2026 à 23:20, il y a 5 heures 38 minutes BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Publié le 23/06/2026 à 23:15, il y a 5 heures 43 minutes EV Nickel Signs LOI Forming High-Grade Nickel Joint Venture for Shaw Dome Projects
Publié le 24/06/2026 à 04:00, il y a 57 minutes Shipping edges closer to onboard carbon mineralisation as IMO endorses Shanghai Qiyao Technology Group Co., Ltd. proposals
Publié le 24/06/2026 à 02:05, il y a 2 heures 52 minutes FRONTERA AND KUPARI ANNOUNCE COMMENCEMENT OF STRATEGIC SALE PROCESS FOR THE JOINTLY OWNED PIEDRAS VERDES COPPER MINE COMPLEX IN SONORA, MEXICO
Publié le 23/06/2026 à 22:20, il y a 6 heures 37 minutes Saudi Properties Portal to Accept Applications for Foreign Real Estate Ownership
Publié le 23/06/2026 à 20:15, il y a 8 heures 43 minutes EQS-Adhoc: OHB SE resolves on the issue of 1,605,388 new shares representing the first tranche of the up to 8.86% capital increase with subscription rights
